Recently, the hottest covid-19 testing concept stock Andon Health Co.Ltd(002432) suddenly issued a supplementary announcement on the evening of the 14th, saying that the U.S. government has the right to terminate the contract at any time due to its own factors. The above meaning means that the U.S. government can request to stop the execution of the contract and cancel subsequent procurement without any reason, and the Seller shall bear the corresponding risks and possible losses.
in addition, the company replied to the letter of concern of Shenzhen Stock Exchange. At present, the company has obtained the authorization of the U.S. FDA EUA and can be sold in the United States, but it has not obtained the Chinese license and cannot be put into use in China. The above contents of the company’s announcement specifically emphasize the possible reduction of antigen detection sensitivity. In the future, the company will strengthen the control over the integrity of the wording of the announcement, but the company has no behavior and motivation to hype the stock price through information disclosure.
As the hottest stock in the recent A-share market, Andon Health Co.Ltd(002432) has harvested 27 trading boards in the past 44 trading days, with a cumulative increase of 1007%. Due to the rapid and substantial spread of the epidemic in Europe and the United States, Andon Health Co.Ltd(002432) successively announced that the company’s household kit Green has successively won large orders in the United States, which has become the fundamental reason for the sharp rise of stock prices.
On January 12, Andon Health Co.Ltd(002432) announced that the U.S. subsidiary had received orders for ihealth covid-19 antigen home self-test OTC kit from New York and Massachusetts. As of the date of the announcement, the cumulative amount of orders and contracts between the U.S. subsidiary and the Department of health of New York was $185 million (about RMB 1.18 billion); The total amount of orders signed with the Executive Office of the Federal Department of health and human services in Massachusetts amounted to US $148 million (about RMB 944 million).
On January 14, Andon Health Co.Ltd(002432) announced a super large contract. In the morning, Andon Health Co.Ltd(002432) announced at the Shenzhen stock exchange that on January 13 local time, the U.S. subsidiary signed a purchase contract with the U.S. ACC to sell ihealth covid-19 antigen home self-test OTC kit products, with a total contract price tax of US $1.275 billion (including freight), about RMB 8.1 billion, It has exceeded 50% of the company’s audited main business income in 2020 (RMB 1.004 billion).
The subject matter of the contract is 250 million copies of ihealth kit. The effective date of the contract is January 12 local time in the United States, and all deliveries shall be completed within 60 days from the effective date; In terms of specific delivery arrangements, the U.S. subsidiary will deliver 25 million copies within 10 days from the signing of the contract, 100 million copies within 30 days, and complete all deliveries within 60 days.
